Now Reading: BrahMos demand surges after Sindoor, next-gen prototype by 2027-28
-
01
BrahMos demand surges after Sindoor, next-gen prototype by 2027-28
The Story in Brief
BrahMos Aerospace CEO Dr Jaiteerth R Joshi said global demand for the supersonic cruise missile surged after it was battle-tested in Operation Sindoor, with the Philippines, Vietnam and Indonesia as foreign customers. Joshi told India Today that the missile's precision and radar-evading capability in combat made it the world's most lethal. He added that all three Indian armed forces were equipped with BrahMos during the operation for the first time.
In a separate interview with ANI reported by the Economic Times, Joshi said the first prototype of the next-generation BrahMos-NG missile is expected by 2027 or 2028, with a 1,500-km range missile still at the conceptual stage. He said countries operating the Sukhoi-30 platform have expressed interest in the air-launched version. BrahMos Aerospace is also expanding its supply chain from 1 to 2 partners per system to 45 sources, and defence exports have reached Rs 38,400 crore with 62.7% annual growth.
Indian Opinion Analysis
Both outlets report the same CEO interview but lead with different news points. India Today leads with demand surging after Operation Sindoor and quotes the CEO that BrahMos became the world's most lethal missile, framing the combat debut as a proven sales asset. The Economic Times leads with the BrahMos-NG prototype timeline of 2027-28 and the 1,500-km range being at the conceptual stage, foregrounding R&D milestones and export interest from specific Sukhoi-30 operators. India Today, alone, names Vietnam and Indonesia as customers after the Philippines, and mentions talks with Russia. The Economic Times omits those country names but adds the 62.7% defence export growth figure (Rs 38,400 crore) and the 45-source supply chain expansion plan. The balanced reading: the CEO confirmed both heightened post-conflict demand and that the longest-range upgrade remains conceptual, not imminent.
Coverage: 2 sources, 2 neutral
Sources (2): indiatoday.in (neutral report), economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
